» Articles » PMID: 36972230

IL-12p40 is Essential but Not Sufficient for Francisella Tularensis LVS Clearance in Chronically Infected Mice

Overview
Journal PLoS One
Date 2023 Mar 27
PMID 36972230
Authors
Affiliations
Soon will be listed here.
Abstract

IL-12p40 plays an important role in F. tularensis Live Vaccine Strain (LVS) clearance that is independent of its functions as a part of the heterodimeric cytokines IL-12p70 or IL-23. In contrast to WT, p35, or p19 knockout (KO) mice, p40 KO mice infected with LVS develop a chronic infection that does not resolve. Here, we further evaluated the role of IL-12p40 in F. tularensis clearance. Despite reduced IFN-γ production, primed splenocytes from p40 KO and p35 KO mice appeared functionally similar to those from WT mice during in vitro co-culture assays of intramacrophage bacterial growth control. Gene expression analysis revealed a subset of genes that were upregulated in re-stimulated WT and p35 KO splenocytes, but not p40 KO splenocytes, and thus are candidates for involvement in F. tularensis clearance. To directly evaluate a potential mechanism for p40 in F. tularensis clearance, we reconstituted protein levels in LVS-infected p40 KO mice using either intermittent injections of p40 homodimer (p80) or treatment with a p40-producing lentivirus construct. Although both delivery strategies yielded readily detectable levels of p40 in sera and spleens, neither treatment had a measurable impact on LVS clearance by p40 KO mice. Taken together, these studies demonstrate that clearance of F. tularensis infection depends on p40, but p40 monomers and/or dimers alone are not sufficient.

References
1.
Wittwer M, Altpeter E, Pilo P, Gygli S, Beuret C, Foucault F . Population Genomics of subsp. and its Implication on the Eco-Epidemiology of Tularemia in Switzerland. Front Cell Infect Microbiol. 2018; 8:89. PMC: 5875085. DOI: 10.3389/fcimb.2018.00089. View

2.
Walter M, Kajiwara N, Karanja P, Castro M, Holtzman M . Interleukin 12 p40 production by barrier epithelial cells during airway inflammation. J Exp Med. 2001; 193(3):339-51. PMC: 2195918. DOI: 10.1084/jem.193.3.339. View

3.
Sjostedt A, North R, Conlan J . The requirement of tumour necrosis factor-alpha and interferon-gamma for the expression of protective immunity to secondary murine tularaemia depends on the size of the challenge inoculum. Microbiology (Reading). 1996; 142 ( Pt 6):1369-1374. DOI: 10.1099/13500872-142-6-1369. View

4.
Mulligan M, Stapleton J, Keitel W, Frey S, Chen W, Rouphael N . Tularemia vaccine: Safety, reactogenicity, "Take" skin reactions, and antibody responses following vaccination with a new lot of the Francisella tularensis live vaccine strain - A phase 2 randomized clinical Trial. Vaccine. 2017; 35(36):4730-4737. PMC: 5800773. DOI: 10.1016/j.vaccine.2017.07.024. View

5.
Magram J, Connaughton S, Warrier R, Carvajal D, Wu C, Ferrante J . IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity. 1996; 4(5):471-81. DOI: 10.1016/s1074-7613(00)80413-6. View